Today's high is the highest price at which the stock has been traded that day.
Today's low
Today's low is the lowest price at which the stock has been traded that day.
52 week high
52W high is the highest price at which the stock has been traded in the last 52 weeks.
52 week low
52W low is the lowest price at which the stock has been traded in the last 52 weeks.
Opening Price
Opening price is the price at which the stock starts trading during that day when the exchange opens.
Prev. Price
Prev. price is the price at which the stock ends trading when the exchange closes. It represents the previous session's close price.
Volume
Volume or trading volume is the total number of an stock traded, both bought and sold, on the exchange for the day.
Lower circuit
Lower circuit is the lowest price to which an stock can fall on a particular trading date.
Upper circuit
Upper circuit is the highest price to which an stock can rise on a particular trading date.
Fundamentals
Market Cap
₹38,900Cr
ROE
13.33%
P/E Ratio(TTM)
41.34
EPS(TTM)
37.09
P/B Ratio
5.24
Dividend Yield
0.26%
Industry P/E
34.27
Book Value
292.74
Debt to Equity
0.17
Face Value
1
Fundamentals
Financial information that is reported quarterly or annually
Market Cap
Market cap is the total market value of all of a company's outstanding shares.
ROE
Return on equity (ROE) is a measure of financial performance, calculated by dividing net income by shareholders' equity.
P/E Ratio(TTM)
P/E (price-to-earnings) ratio is the ratio of a company's share price to its earnings per share (EPS). P/E ratio is used to determine whether a company is overvalued or undervalued.
Book Value
The amount of money that a company's shareholders would earn if it is liquidated and has paid off all liabilities.
P/B Ratio
P/B (price-to-book) ratio is the ratio of a company's share price to its book value. Any value under 1.0 is considered a good P/B value.
Dividend Yield
Dividend yield percentage is the amount of money a company pays its shareholders for owning a share of its stock divided by its current stock price.
Industry P/E
The average P/E ratio of all the stocks in any sector. Different sectors consider different P/E ratios as healthy.
EPS(TTM)
Earnings per share (EPS) is a company's net profit divided by the number of its common outstanding shares. It indicates how much money a company makes for each share of its stock.
Face Value
The original value of a company's stock as written in its books of accounts and its share certificates. Also known as par value, it is fixed when the stock is first issued.
Debt to Equity
Debt to Equity is the percentage of the total liabilities of a company (debt) to its shareholders' equity. A higher debt to equity means the company is using more debt funds than equity funds, and a lower debt to equity means more equity than debt funds.
*The above information is sourced from Refinitiv. It is on a consolidated balance sheet basis and excludes extraordinary items.
Ipca Laboratories Limited, established in 1949, is a fully integrated Indian pharmaceutical company that develops, manufactures, and markets a wide range of medicines. The company's primary business is the manufacturing and marketing of pharmaceuticals, producing both active ingredients (APIs) and over 350 ready-to-use formulations. In the Indian market, the company operates through 22 marketing divisions and is ranked as the 16th largest in the domestic formulations business. It has a vast global presence, with its products being exported to more than 100 countries across the world. Ipca drives innovation through its R&D centers, focusing on new processes for APIs and developing modern drug delivery systems. As part of its sustainability initiatives, the company has been investing in renewable energy projects such as wind and solar power generation for its own use.;
IPCA Labs saw an NSE block trade of Rs. 60.65 cr for 381,656 shares at Rs. 1,589 each.
Livesquawk •
IPCA Labs forecasts 10-11% overall growth, with branded, generic, and domestic segments rising 10-12%.
EBITDA margin may improve by 1.5% annually, indicating a 300 bps increase over two years.